Estimating the Force of Infection for Dengue Virus Using Repeated Serosurveys, Ouagadougou, Burkina Faso

被引:7
|
作者
Lim, Jacqueline K. [1 ,2 ]
Carabali, Mabel [1 ,4 ]
Edwards, Tansy [2 ]
Barro, Ahmed [5 ]
Lee, Jung-Seok [1 ]
Dahourou, Desire [3 ,6 ]
Lee, Kang Sung [1 ]
Nikiema, Teguewende [3 ]
Shin, Mee Young [1 ]
Bonnet, Emmanuel [7 ]
Kagone, Therese [3 ]
Kaba, Losseni [8 ]
Namkung, Suk [1 ]
Som, Paul-Andre [5 ]
Yang, Jae Seung [1 ]
Ridde, Valery [7 ]
Yoon, In-Kyu [9 ]
Alexander, Neal [2 ]
Seydou, Yaro [3 ]
机构
[1] Int Vaccine Inst, Seoul, South Korea
[2] London Sch Hyg & Trop Med, London, England
[3] Ctr MURAZ, Bobo Dioulasso, Burkina Faso
[4] McGill Univ, Montreal, PQ, Canada
[5] Act Gouvernance Integrat Renforcement Program Equ, Ouagadougou, Burkina Faso
[6] Inst Rech Sci Sante, Ouagadougou, Burkina Faso
[7] Univ Paris, Inst Res Sustainable Dev, Paris, France
[8] Ctr Natl Transfus Sanguine, Ouagadougou, Burkina Faso
[9] Coalit Epidem Preparedness Innovat, Washington, DC USA
基金
英国医学研究理事会; 加拿大健康研究院;
关键词
LINKED-IMMUNOSORBENT-ASSAY; HEMAGGLUTINATION INHIBITION; CHILDREN; SEROPREVALENCE; TRANSMISSION; PREVALENCE; EPIDEMIC; FEVER;
D O I
10.3201/eid2701.191650
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Because of limited data on dengue virus in Burkina Faso, we conducted 4 consecutive age-stratified longitudinal serologic surveys, approximate to 6 months apart, among persons 1-55 years of age, during June 2015-March 2017, which included a 2016 outbreak. The seroconversion rate before the serosurvey enrollment was estimated by binomial regression, taking age as the duration of exposure, and assuming constant force of infection (FOI) over age and calendar time. We calculated FOI between consecutive surveys and rate ratios for potentially associated characteristics based on seroconversion using the duration of intervals. Among 2,897 persons at enrollment, 66.3% were IgG-positive, and estimated annual FOI was 5.95%. Of 1,269 enrollees participating in all 4 serosurveys, 438 were IgG-negative at enrollment. The annualized FOI ranged from 10% to 20% (during the 2016 outbreak). Overall, we observed high FOI for dengue. These results could support decision-making about control and preventive measures for dengue.
引用
收藏
页码:130 / 139
页数:10
相关论文
共 50 条
  • [31] Urban Flood Modeling Using 2D Shallow-Water Equations in Ouagadougou, Burkina Faso
    Coulibaly, Gnenakantanhan
    Leye, Babacar
    Tazen, Fowe
    Mounirou, Lawani Adjadi
    Karambiri, Harouna
    WATER, 2020, 12 (08)
  • [32] First comprehensive analysis of Aedes aegypti bionomics during an arbovirus outbreak in west Africa: Dengue in Ouagadougou, Burkina Faso, 2016-2017
    Badolo, Athanase
    Sombie, Aboubacar
    Yameogo, Felix
    Wangrawa, Dimitri W.
    Sanon, Aboubakar
    Pignatelli, Patricia M.
    Sanon, Antoine
    Viana, Mafalda
    Kanuka, Hirotaka
    Weetman, David
    Mccall, Philip J.
    PLOS NEGLECTED TROPICAL DISEASES, 2022, 16 (07):
  • [33] Clinical and epidemiologic characteristics associated with dengue during and outside the 2016 outbreak identified in health facility-based surveillance in Ouagadougou, Burkina Faso
    Lim, Jacqueline K.
    Seydou, Yaro
    Carabali, Mabel
    Barro, Ahmed
    Dahourou, Desire Lucien
    Lee, Kang Sung
    Nikiema, Teguewende
    Namkung, Suk
    Lee, Jung-Seok
    Shin, Mee Young
    Bonnet, Emmanuel
    Kagone, Therese
    Kaba, Losseni
    Edwards, Tansy
    Some, Paul-Andre
    Yang, Jae Seung
    Alexander, Neal
    Yoon, In-Kyu
    Ridde, Valery
    PLOS NEGLECTED TROPICAL DISEASES, 2019, 13 (12):
  • [34] Human immunodeficiency virus type 1 drug resistance in a subset of mothers and their infants receiving antiretroviral treatment in Ouagadougou, Burkina Faso
    Soubeiga, Serge Theophile
    Bazie, Bapio Valery Jean Telesphore Elvira
    Compaore, Tegwinde Rebeca
    Ouattara, Abdoul Karim
    Zohoncon, Theodora Mahoukede
    Obiri-Yeboah, Dorcas
    Yonli, Albert Theophane
    Zongo, Arsene
    Traore, Lassina
    Pietra, Virginio
    Akpona, Simon
    Diagbouga, Serge
    Simpore, Jacques
    JOURNAL OF PUBLIC HEALTH IN AFRICA, 2018, 9 (01) : 65 - 69
  • [35] Men who have sex with men (MSM) and HIV infection in Ouagadougou, Burkina Faso: Knowledge, attitudes, practices and seroprevalence survey
    Dah, T. T. E.
    Orne-Gliemann, J.
    Guiard-Schmid, J. B.
    Becquet, R.
    Larmarange, J.
    REVUE D EPIDEMIOLOGIE ET DE SANTE PUBLIQUE, 2016, 64 (04): : 295 - 300
  • [36] HCV and HIV co-infection in pregnant women attending St. Camille Medical Centre in Ouagadougou (Burkina faso)
    Simpore, J
    Ilboudo, D
    Samandoulougou, A
    Guardo, P
    Castronovo, P
    Musumeci, S
    JOURNAL OF MEDICAL VIROLOGY, 2005, 75 (02) : 209 - 212
  • [37] Insecticidal activity of essential oils from six aromatic plants against Aedes aegypti, dengue vector from two localities of Ouagadougou, Burkina Faso
    Yameogo, Felix
    Wangrawa, Dimitri Wendgida
    Sombie, Aboubacar
    Sanon, Antoine
    Badolo, Athanase
    ARTHROPOD-PLANT INTERACTIONS, 2021, 15 (04) : 627 - 634
  • [38] Insecticidal activity of essential oils from six aromatic plants against Aedes aegypti, dengue vector from two localities of Ouagadougou, Burkina Faso
    Félix Yaméogo
    Dimitri Wendgida Wangrawa
    Aboubacar Sombié
    Antoine Sanon
    Athanase Badolo
    Arthropod-Plant Interactions, 2021, 15 : 627 - 634
  • [39] Epidemiology of Herpes Simplex Virus Type 2 Infection in Rural and Urban Burkina Faso
    Kirakoya-Samadoulougou, Fati
    Nagot, Nicolas
    Defer, Marie-Christine
    Yaro, Seydou
    Fao, Paulin
    Ilboudo, Francois
    Langani, Youssouf
    Meda, Nicolas
    Robert, Annie
    SEXUALLY TRANSMITTED DISEASES, 2011, 38 (02) : 117 - 123
  • [40] Estimating Dengue Outbreak Thresholds in West Africa: A Comprehensive Analysis of Climatic Influences in Burkina Faso, 2018-2024
    Otshudiema, John Otokoye
    Diao, Watton R.
    Ouedraogo, Sonia Marie Wend-Kuuni
    Kapete, Alain Ngoy
    Moyenga, Laurent
    Chanda, Emmanuel
    Traore, Tieble
    Ramadan, Otim Patrick
    Zumla, Alimuddin
    TROPICAL MEDICINE AND INFECTIOUS DISEASE, 2025, 10 (03)